Showing results (71-80 of 101) with videos related to
Sort By:
Pageof 11
Pharmacotherapy|May 1, 1993
The drug data base of the Pawtucket Heart Health Program: development and descriptionM M Barbour, A L Hume, A R Assaf, et al.Epidemiology (Cambridge, Mass.)|July 1, 1995
Is the use of psychotropic drugs associated with increased risk of ischemic heart disease?K L Lapane, S Zierler, T M Lasater, et al.The New England Journal of Medicine|September 23, 1993
Possible influence of the prospective payment system on the assignment of discharge diagnoses for coronary heart diseaseA R Assaf, K L Lapane, J L McKenney, et al.Medicine and Science in Sports and Exercise|January 1, 1982
Assessing VO2max in epidemiologic studies: modification of the Astrand-Rhyming testS F Siconolfi, E M Cullinane, R A Carleton, et al.Journal of the American College of Cardiology|May 1, 1991
The threshold for myocardial ischemia varies in patients with coronary artery disease depending on the exercise protocolC E Garber, R A Carleton, D N Camaione, et al.International Journal of Epidemiology|March 1, 1989
A new approach to surveillance for acute myocardial infarction: reproducibility and cost efficiencyS M McKinlay, R A Carleton, J L McKenney, et al.JAMA|May 14, 1982
Incidence of death during jogging in Rhode Island from 1975 through 1980P D Thompson, E J Funk, R A Carleton, et al.Psychosomatic Medicine|November 1, 1995
Is a history of depressive symptoms associated with an increased risk of infertility in women?K L Lapane, S Zierler, T M Lasater, et al.Sozial- Und Praventivmedizin|January 1, 1995
Measuring cardiovascular disease risk factor levels: international comparisons between Bremen-north/west (Germany) and two southeastern New England (USA) citiesA R Assaf, U Helmert, T L Lasater, et al.Preventive Medicine|March 12, 1999
The effect of physician office visits on CHD risk factor modification as part of a worksite cholesterol screening programJ S Wang, E C Carson, K L Lapane, et al.Pageof 11